Cash flow deterioration due to delayed collection of medical reimbursement claims
First written in FY2019. 4 of 10 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026MitigatedAnnual report
「Net cash provided by operating activities was ¥590.563 million, compared with net cash used of ¥319.199 million in the previous fiscal year. The main factors behind the increase were the recognition of ¥642.968 million in profit before income taxes and the ¥272.869 million decrease in trade receivables.」
Operating cash flow improved from an outflow of ¥319.199 million in the previous fiscal year to an inflow of ¥590.563 million, while trade receivables also declined. - 2026-05-15MitigatedRevision of earnings forecasts
「Net cash provided by operating activities was ¥590.563 million, compared with net cash used of ¥319.199 million in the previous fiscal year. The main factors behind the increase were the recognition of ¥642.968 million in profit before income taxes and the ¥272.869 million decrease in trade receivables.」
Operating cash flow turned from an outflow into an inflow, while trade receivables also declined. The disclosure indicates an improvement in cash outflow conditions. - FY2026-H1MitigatedAnnual report
「Cash used in operating activities was ¥46.164 million, compared with ¥465.276 million used in the same interim period of the previous year. This was mainly due to increases of ¥27.063 million in trade receivables and ¥433.272 million in advances paid.」
Cash used in operating activities declined from ¥465.276 million in the same period of the previous year to ¥46.164 million. However, the increase in advances paid remained a source of cash outflow. - FY2025WorsenedAnnual report
「Cash flow from operating activities was an outflow of ¥319.199 million, compared with an inflow of ¥172.023 million in the previous fiscal year. The main factors behind the outflow were the recording of a ¥141.751 million loss before income taxes and other adjustments, an increase of ¥283.719 million in trade receivables and an increase of ¥227.098 million in advances paid.」
Operating cash flow shifted from ¥172.023 million of cash provided in the previous fiscal year to ¥319.199 million of cash used, with increases in trade receivables and advances paid driving the cash outflow. - FY2025-H1WorsenedAnnual report
「Cash used in operating activities was ¥465.276 million, compared with cash provided of ¥95.513 million in the same interim period of the previous year. This was mainly due to increases of ¥339.760 million in trade receivables and ¥231.539 million in advances paid.」
Operating cash flow shifted from ¥95.513 million of cash provided in the same period of the previous year to ¥465.276 million of cash used. Increases in trade receivables and advances paid were cited as factors behind the cash outflow. The filing does not explicitly identify delayed claims submissions as the cause. - FY2024RestatedAnnual report
「The Group works to ensure the accuracy and speed of claims submission by maintaining manuals and using systems, and complies with applicable laws and regulations. However, if claims submissions are significantly delayed or returned claims increase substantially for any reason, the substantial extension of the collection period could worsen the Group's cash flow and affect its financial condition.」
The risk of prolonged collection periods and deteriorating cash flow due to delayed claims submissions and an increase in returned claims has been reiterated. - FY2023RestatedAnnual report
「The Group works to ensure the accuracy and speed of claims submission by maintaining manuals and using systems, and complies with applicable laws and regulations. However, if claims submissions are significantly delayed or returned claims increase substantially for any reason, the substantial extension of the collection period could worsen the Group's cash flow and affect its financial condition.」
The risk of prolonged collection periods and deteriorating cash flow due to delayed claims submissions and an increase in returned claims has been reiterated. - FY2022RestatedAnnual report
「The Group works to ensure the accuracy and speed of claims submission by maintaining manuals and using systems, and complies with applicable laws and regulations. However, if claims submissions are significantly delayed or returned claims increase substantially for any reason, the substantial extension of the collection period could worsen the Group's cash flow and affect its financial condition.」
The risk of prolonged collection periods and deteriorating cash flow due to delayed claims submissions and an increase in returned claims has been reiterated. - FY2020RestatedAnnual report
「The Company works to ensure the accuracy and speed of claims submission by maintaining manuals and using systems, and complies with applicable laws and regulations. However, if claims submissions are significantly delayed or returned claims increase substantially for any reason, the substantial extension of the collection period could worsen the Company's cash flow and affect its financial condition.」
The risk of prolonged collection periods and deteriorating cash flow due to delayed claims submissions and an increase in returned claims has been reiterated. - FY2019First statedAnnual report
「The Company works to ensure the accuracy and speed of claims submission by maintaining manuals and using systems, and complies with applicable laws and regulations. However, if claims submissions are significantly delayed or returned claims increase substantially for any reason, the substantial extension of the collection period could worsen the Company's cash flow and affect its financial condition.」
This shows how the collection period from billing insurers to receiving payment, together with returned claims, affects working capital.